Taro Pharmaceutical Industries Ltd TARO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TARO is a good fit for your portfolio.
News
-
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
-
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates TAST, TARO, MDC
-
INVESTIGATION ALERT: Halper Sadeh LLC Investigates HARP, TARO, FFNW
-
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO
-
Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm
-
Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
-
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ANSS, TARO, MDC
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI)
Trading Information
- Previous Close Price
- $42.24
- Day Range
- $42.14–42.36
- 52-Week Range
- $24.22–43.40
- Bid/Ask
- $42.09 / $42.64
- Market Cap
- $1.59 Bil
- Volume/Avg
- 31,436 / 49,383
Key Statistics
- Price/Earnings (Normalized)
- 33.44
- Price/Sales
- 2.59
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,554
- Website
- https://www.taro.com
Competitors
Valuation
|
Metric
|
TARO
|
PRGO
|
TEVA
|
|---|---|---|---|
Price/Earnings (Normalized) | 33.44 | 11.61 | 4.99 |
Price/Book Value | 0.89 | 0.85 | 1.91 |
Price/Sales | 2.59 | 0.87 | 0.90 |
Price/Cash Flow | 20.62 | 8.74 | 9.93 |
Price/Earnings
TARO
PRGO
TEVA
Financial Strength
|
Metric
|
TARO
|
PRGO
|
TEVA
|
|---|---|---|---|
Quick Ratio | 3.03 | 0.94 | 0.54 |
Current Ratio | 3.60 | 1.79 | 1.02 |
Interest Coverage | — | 0.95 | 0.39 |
Quick Ratio
TARO
PRGO
TEVA
Profitability
|
Metric
|
TARO
|
PRGO
|
TEVA
|
|---|---|---|---|
Return on Assets (Normalized) | 2.15% | 3.23% | 6.70% |
Return on Equity (Normalized) | 2.62% | 7.32% | 39.00% |
Return on Invested Capital (Normalized) | 0.92% | 5.60% | 13.54% |
Return on Assets
TARO
PRGO
TEVA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Yrcqgxdtc | Qgffdmm | $70.5 Bil | |
ZTS
| Zoetis Inc Class A | Sfljydcxl | Vng | $70.0 Bil | |
HLN
| Haleon PLC ADR | Cvwyxcys | Qccx | $36.3 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Yvrhznsp | Grt | $14.3 Bil | |
VTRS
| Viatris Inc | Pstcjfg | Zzvx | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Cljrrhksj | Vqht | $12.0 Bil | |
CTLT
| Catalent Inc | Dnvbpbrl | Swfsyz | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Xzqbdrfcd | Tyjnr | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Xcyzbyjr | Whk | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wtqlmcv | Dwytck | $3.4 Bil |